학술논문
Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial
Document Type
Article
Author
Source
In Lancet Oncology 2011 12(2):144-152
Subject
Language
ISSN
1470-2045